• Laser energy, like radiofrequency (RF) and microwave energy, induces electromagnetic heating to raise the temperature of tissues to lethal levels. It is a fast, precise and relatively tissue-insensitive technique, and can be delivered very easily and safely with simultaneous technique to obtain large areas of coagulation.
• The laser technique use very thin applicators considerably smaller (<1 mm) than radiofrequency ablation electrodes and microwave ablation antenna. In case of lesions ≥ 3 cm the laser ablation (LA) shows the same efficacy and safety profile than RF with a shorter (up to 4-6 min) treatment time per session.
• Usually, one to two fibers with or without pullback technique are used to treat nodule up to 1.5-2.5 cm in diameter and four fibers with fiber tips arranged in a square configuration to treat nodules from 2.5 to 4.0 cm. With pullback technique is possible to treat nodule greater than 4 cm.
• Thanks to fine applicators, unlike RF, laser light technology is safer and more suitable for ablating lesions in high-risk sites or in location that are difficult to reach. It is possible to obtain complete ablation in high percentage of cases (up to 93%) without using special technical devices to protect adjacent structures.
• The possibility to use multiple fine needles allows to obtain ablation area different in size, enabling to treat lesions different in size or multiple small lesions in the same session sparing the normal surrounding parenchyma.
• LA technique can become the ablative technique of choice in patients with multiple or recurrent small lesions of variable size ranging from 5-6 mm to 3-4 cm in diameter. Therefore, patients with disseminated liver metastases of variable size from neuroendocrine tumors can be treated at different times with intention to reduce tumor burden and ameliorate local or general symptoms. In addition the laser technique can be repeated several times safely over a period of years.
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• In case of paucilesional disease multimodality locoregional ischemic treatments alternating catheter-based technique (i.e., radioembolization, ethiodized oil-based or drug-eluting bead [DEB] , bland embolization) and laser thermal ablation can be performed even at multiple treatment sessions.
• LA, thanks to the recent introduction in clinical practice of a novel guide system that facilitates both the parallel insertion of multiple thin needles and their positioning in geometrical configurations to maximize the ablative effect, is more effective in achieving large volumes of necrosis and then effectively treat with safety lesions of 5-6 cm in diameter at any location without using sequential combined treatment.
• Unresectable solitary large metastatic lesion can be successfully ablated with LA followed by chemoembolization. LA reduce the initial volume of the large lesion and then the TACE can act more effectively on the smaller volume of residual tissue.
• LA with or without chemoembolization induce a marked and durable control either of functional and mass symptoms.
Aim
To evaluate the effectiveness of laser ablation (LA) with or without selective transarterial chemoembolization in patients with large, isolated or oligonodular unresectable neuroendocrine liver matastases.
Materials & methods
Ten patients (mean age: 53.6 years ± 14.1; range: 24-79) with neuroendocrine tumors (NETs) and 13 liver matastases (mean diameter: 4.3 ± 2.8 cm; range: 1.5-12) underwent LA alone (n = 9) or LA followed by selective transarterial chemoembolization (n = 3).
Results
Complete response was obtained in six patients with LA alone and in two patients with combined treatment. The 5-year overall survival rates from the initial diagnosis and posttreatment were 80 and 50%, respectively.
Conclusion
This treatment modality may provide effective control of tumor burden and general symptoms improvement in patients with limited but unresectable disease.
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Methods
Preoperative MR showed a tumor of 2.3*2.5 cm in size in left liver ( Figure A) . A curved linear array echoendoscope was inserted orally. With the echoendoscope, the deep lesions in left liver were easily visualized from the cardia of stomach, and punctured with a 22-gauge aspiration needle. Then the needle core was withdrawn and the super long laser fiber (3 meters total length) was inserted into needle sheath outside of the pin end within 1 cm. The nidus was ablated by a Nd:YAG laser fiber with a wavelength of 1064nm, which has an output power of 5W for 1800J (Echolaser X4, ESAOTE, Italy). The ablation was not stopped untill hyperechoic area overlaying the entire lesions ( Figure B) .
Results
EUS-guided Nd:YAG laser ablation of left liver cancers were successfully completed. He had a good postoperative condition with no complications. In four-month follow-up, MR indicated that the lesion had complete response (Figure C and D) .
Conclusions
EUS-guided LA could be a technically effective method in selected patients with left liver tumors. In the future, the safety of this technique need to be confirmed in the larger and prospective trials. The "Aggiornamenti in Senologia" congress, in which Elesta took part as a sponsor, represented a general update in the breast medicine field. The matters treated ranged from the prevention techniques to the last findings in the diagnostic field and the different possible approaches to breast lesions.
Endoscopic ultrasonography guided
One of the most interesting session was on Thursday morning, when Dr. J. Nori presented the results of his clinical study about the percutaneous laser thermal ablation of breast cancer. After a brief introduction in which Dr. Nori gave a review about the different techniques used to approach breast lesions, he presented the results of his study, started two years ago at Careggi Hospital (Florence, Italy).
The study is currently ongoing and to date has seen the enrolment of about 30 patients with ductal carcinoma in-situ. The treatment is performed in the operating room under local anaesthesia and lasts about 30 minutes, during which the lesion is thermally ablated using laser energy, that can reach the tissue through an optical fiber.
During a two years follow-up all the lesions with a diameter <1.5 cm, controlled using different imaging exams, did not present relapse and all the patients resulted disease-free. No complications were registered. The main objectives of this course were to review the latest news in thyroid interventional diagnostic criteria and applications in the presence of thyroid nodules and to offer tools to use in daily clinical practice when executing interventional procedures on the neck.
This live educational course put at learners' disposal up-to-date knowledge on thyroid ultrasonography and its novel applications such as ultrasound guided Fine Needle Aspiration, percutaneous ethanol injection and laser treatment for benign nodules.
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